Founded 2007 by Jan Mikael Nordfors MD, only for informational purposes. Shall not replace the advice of a skilled therapist.
You are here
Items per page
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
Durable responses with the antiangiogenic metronomic regimen RT-PEPC in elderly patients with recurrent mantle cell lymphoma
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide r
The Mikael Nordfors site operates under a Creative Commons License
Copyright © 2020,